Gastrointestinal cancer: Combine and conquer.

Nature reviews. Clinical oncology ·Vol. 9 ·No. 2 ·2012-01-17 ·Pages 67

Kirk R

Abstract

暂无摘要

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Kirk Rebecca

References (1)

1 references, click to expand

Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer.
Cancer Res. 2012 Feb 1;72(3):779-89 PMID: 22180495

Article Info

Journal

Nature reviews. Clinical oncology

Abbr.

Nat Rev Clin Oncol

ISSN

1759-4782

DOI

Published

2012-01-17

Epub

2012-00-17

Pages

Language

English

Region

England

NLM ID

101500077

Corrections

CommentOn

PMID: 22180495

External Links

Analysis Services